Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Contraception |
Dose: Active Tablet – 1 tablet Frequency: once daily by mouth Duration: 21 days |
|
Indication: Contraception Condition: Post-active tablet interval |
Dose: Brown Iron Tablet – 1 tablet Frequency: once daily by mouth Duration: 7 days Note: Start with next pack after the usual 7 day brown inactive pill interval. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: Tablet – No approved pediatric dosage available Note: No approved pediatric dosage available |
Administration
- Take daily at same time
- Preferably after evening meal
Side Effect
- Nausea
- vomiting
- Cholestatic jaundice
- Thrombosis
- BP rise
- Rash
- Headache
- migraine
- mood change
- Breast tenderness
- pain
- enlargement
- secretion
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
CYP1A2 and CYP3A4 inducers (e.g. aminoglutethimide, carbamazepine, phenobarbital, rifampin)
|
May decrease effects of estradiol
|
|
Hydrocortisone, Prednisolone
|
May enhance effects when used together
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Thromboembolic Disorders
|
Risk of blood clots
|
|
Cardiovascular Diseases
|
Risk of blood clots
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a dry place at 2°C-25°C, away from light. Keep out of reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.